Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
D001091:Arachidonate Lipoxygenases; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D004804:Eosinophils / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007975:Leukotriene B4 / Q000494:pharmacology*; D008084:Lipoxygenase / Q000378:metabolism*; D008715:Methionine / Q000031:analogs & derivatives*; D009239:N-Formylmethionine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D001095:Arachidonic Acids; D009842:Oligopeptides; D007975:Leukotriene B4; D016718:Arachidonic Acid; D000001:Calcimycin; D009239:N-Formylmethionine; D009240:N-Formylmethionine Leucyl-Phenylalanine; D008715:Methionine; D001091:Arachidonate Lipoxygenases; D008084:Lipoxygenase